340 related articles for article (PubMed ID: 26170013)
1. Investigations of renal function using the level of neutrophil gelatinase-associated lipocalin associated with single-dose of cisplatin during chemotherapy.
Maghsoudi O; Mirjalili SH; Dolatabadi M; Joshaghani MF; Zarea M; Yahaghi E; Mokarizadeh A
Diagn Pathol; 2015 Jul; 10():98. PubMed ID: 26170013
[TBL] [Abstract][Full Text] [Related]
2. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study.
Gaspari F; Cravedi P; Mandalà M; Perico N; de Leon FR; Stucchi N; Ferrari S; Labianca R; Remuzzi G; Ruggenenti P
Nephron Clin Pract; 2010; 115(2):c154-60. PubMed ID: 20407275
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Quintavalle C; Anselmi CV; De Micco F; Roscigno G; Visconti G; Golia B; Focaccio A; Ricciardelli B; Perna E; Papa L; Donnarumma E; Condorelli G; Briguori C
Circ Cardiovasc Interv; 2015 Sep; 8(9):e002673. PubMed ID: 26333343
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
[TBL] [Abstract][Full Text] [Related]
5. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase associated lipocalin as an indicator of acute kidney injury and inflammation in burned children.
Yavuz S; Anarat A; Acartürk S; Dalay AC; Kesiktaş E; Yavuz M; Acartürk TO
Burns; 2014 Jun; 40(4):648-54. PubMed ID: 24060429
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
[TBL] [Abstract][Full Text] [Related]
8. Plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) in dogs with acute kidney injury or chronic kidney disease.
Steinbach S; Weis J; Schweighauser A; Francey T; Neiger R
J Vet Intern Med; 2014; 28(2):264-9. PubMed ID: 24417647
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin in dogs with naturally occurring renal diseases.
Hsu WL; Lin YS; Hu YY; Wong ML; Lin FY; Lee YJ
J Vet Intern Med; 2014; 28(2):437-42. PubMed ID: 24417186
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil gelatinase-associated lipocalin (NGAL) and endothelial progenitor cells (EPCs) evaluation in aortic aneurysm repair.
Lacquaniti A; Giardina M; Lucisano S; Messina R; Buemi A; Risitano CD; Chirico V; Buemi M; David A
Curr Vasc Pharmacol; 2013 Nov; 11(6):1001-10. PubMed ID: 22724477
[TBL] [Abstract][Full Text] [Related]
11. Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients.
Taghizadeh-Ghehi M; Sarayani A; Ashouri A; Ataei S; Moslehi A; Hadjibabaie M
Ren Fail; 2015 Jul; 37(6):994-8. PubMed ID: 25945602
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
Bolignano D; Lacquaniti A; Coppolino G; Campo S; Arena A; Buemi M
Kidney Blood Press Res; 2008; 31(4):255-8. PubMed ID: 18600028
[TBL] [Abstract][Full Text] [Related]
13. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.
Balkanay OO; Goksedef D; Omeroglu SN; Ipek G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):209-14. PubMed ID: 25392341
[TBL] [Abstract][Full Text] [Related]
14. Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise.
Lippi G; Sanchis-Gomar F; Salvagno GL; Aloe R; Schena F; Guidi GC
Clin Chem Lab Med; 2012 Feb; 50(9):1585-9. PubMed ID: 22962218
[TBL] [Abstract][Full Text] [Related]
15. Impact of severe sepsis on serum and urinary biomarkers of acute kidney injury in critically ill children: an observational study.
Di Nardo M; Ficarella A; Ricci Z; Luciano R; Stoppa F; Picardo S; Picca S; Muraca M; Cogo P
Blood Purif; 2013; 35(1-3):172-6. PubMed ID: 23428967
[TBL] [Abstract][Full Text] [Related]
16. Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis.
Vanmassenhove J; Glorieux G; Lameire N; Hoste E; Dhondt A; Vanholder R; Van Biesen W
BMC Nephrol; 2015 Feb; 16():18. PubMed ID: 25868473
[TBL] [Abstract][Full Text] [Related]
17. Is neutrophil gelatinase-associated lipocalin an optimal marker of renal function and injury in liver transplant recipients?
Hryniewiecka E; Gala K; Krawczyk M; Pączek L
Transplant Proc; 2014 Oct; 46(8):2782-5. PubMed ID: 25380917
[TBL] [Abstract][Full Text] [Related]
18. Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
Tasanarong A; Hutayanon P; Piyayotai D
BMC Nephrol; 2013 Dec; 14():270. PubMed ID: 24305547
[TBL] [Abstract][Full Text] [Related]
19. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases.
Nishida M; Kawakatsu H; Okumura Y; Hamaoka K
Pediatr Int; 2010 Aug; 52(4):563-8. PubMed ID: 20059722
[TBL] [Abstract][Full Text] [Related]
20. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass.
Tuladhar SM; Püntmann VO; Soni M; Punjabi PP; Bogle RG
J Cardiovasc Pharmacol; 2009 Mar; 53(3):261-6. PubMed ID: 19247188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
